Zieger K - Search Results

1

Long term follow-up of superficial invasive bladder carcinoma with or without concomitant epithelial atypia--recurrence and progression.

Zieger K, Olsen PR, Wolf H, Højgaard K. Zieger K, et al. Scand J Urol Nephrol. 2002 Feb;36(1):52-9. doi: 10.1080/003655902317259373. Scand J Urol Nephrol. 2002. PMID: 12002359

2

Long-term survival of patients with bladder tumours: the significance of risk factors.

Zieger K, Wolf H, Olsen PR, Højgaard K. Zieger K, et al. Br J Urol. 1998 Nov;82(5):667-72. doi: 10.1046/j.1464-410x.1998.00848.x. Br J Urol. 1998. PMID: 9839581

3

Long-term follow-up of noninvasive bladder tumours (stage Ta): recurrence and progression.

Zieger K, Wolf H, Olsen PR, Hojgaard K. Zieger K, et al. BJU Int. 2000 May;85(7):824-8. doi: 10.1046/j.1464-410x.2000.00547.x. BJU Int. 2000. PMID: 10792160

4

A molecular signature in superficial bladder carcinoma predicts clinical outcome.

Dyrskjøt L, Zieger K, Kruhøffer M, Thykjaer T, Jensen JL, Primdahl H, Aziz N, Marcussen N, Møller K, Orntoft TF. Dyrskjøt L, et al. Among authors: zieger k. Clin Cancer Res. 2005 Jun 1;11(11):4029-36. doi: 10.1158/1078-0432.CCR-04-2095. Clin Cancer Res. 2005. PMID: 15930337

5

Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.

Zieger K, Dyrskjøt L, Wiuf C, Jensen JL, Andersen CL, Jensen KM, Ørntoft TF. Zieger K, et al. Clin Cancer Res. 2005 Nov 1;11(21):7709-19. doi: 10.1158/1078-0432.CCR-05-1130. Clin Cancer Res. 2005. PMID: 16278391

6

Recent developments in molecular profiling of bladder cancer.

Ørntoft TF, Zieger K, Dyrskjøt L. Ørntoft TF, et al. Among authors: zieger k. Curr Opin Urol. 2006 Sep;16(5):377-81. doi: 10.1097/01.mou.0000240313.16324.d3. Curr Opin Urol. 2006. PMID: 16905986 Review.

7

Recent advances in high-throughput molecular marker identification for superficial and invasive bladder cancers.

Dyrskjot L, Zieger K, Orntoft TF. Dyrskjot L, et al. Among authors: zieger k. Front Biosci. 2007 Jan 1;12:2063-73. doi: 10.2741/2211. Front Biosci. 2007. PMID: 17127444 Review.

8

Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study.

Dyrskjøt L, Zieger K, Real FX, Malats N, Carrato A, Hurst C, Kotwal S, Knowles M, Malmström PU, de la Torre M, Wester K, Allory Y, Vordos D, Caillault A, Radvanyi F, Hein AM, Jensen JL, Jensen KM, Marcussen N, Orntoft TF. Dyrskjøt L, et al. Among authors: zieger k. Clin Cancer Res. 2007 Jun 15;13(12):3545-51. doi: 10.1158/1078-0432.CCR-06-2940. Clin Cancer Res. 2007. PMID: 17575217 Free article.

9

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer.

Zieger K, Wiuf C, Jensen KM, Ørntoft TF, Dyrskjøt L. Zieger K, et al. BMC Cancer. 2009 May 16;9:149. doi: 10.1186/1471-2407-9-149. BMC Cancer. 2009. PMID: 19445696 Free PMC article.

10

Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.

Brems-Eskildsen AS, Zieger K, Toldbod H, Holcomb C, Higuchi R, Mansilla F, Munksgaard PP, Borre M, Ørntoft TF, Dyrskjøt L. Brems-Eskildsen AS, et al. Among authors: zieger k. BMC Cancer. 2010 Nov 24;10:646. doi: 10.1186/1471-2407-10-646. BMC Cancer. 2010. PMID: 21106093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters